Journal profile · Cardiac & Cardiovascular Systems

Circulation-Heart Failure

ISSN 1941-3289 · eISSN 1941-3297 · Lippincott Williams and Wilkins Ltd. · UNITED STATES · Bimonthly · Founded 2008

Circulation-Heart Failure: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 8.24; hybrid open access; median 160 days to acceptance (57 articles, last 24 months); community-reported acceptance: fairly hard; 186 articles in 2025; indexed in SCIE and Scopus.

Impact factor8.24Latest value listed by LetPub
CAS zoneZone 1 · Medicine2025 upgraded edition, major category · Top journal · 2026 Xinrui edition Zone 1 · Medicine
Review time160 daysMedian, submission to acceptance · 57 articles, last 24 months · Crossref
APC—No source gives fee information
AcceptanceFairly hardCommunity average
Articles per year1862025 · OpenAlex count

Scope

Aims, scope and focus

Circulation-Heart Failure is published by Lippincott Williams and Wilkins Ltd. and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Heart Failure Treatment and Management, Cardiovascular Function and Risk Factors and Mechanical Circulatory Support Devices, together about 41.9% of its articles. Its main subfields are Cardiology and Cardiovascular Medicine. (generated from OpenAlex topic counts and CAS ranking data)

High-quality mechanistic and clinically relevant science to keep clinicians at the forefront of the latest advancements in the diagnosis and treatment of heart failure

From the journal's Aims & Scope

Research area (LetPub): Cardiac & Cardiovascular Systems

Editor-in-chief Nancy K. SweitzerPublisher website

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Heart Failure Treatment and ManagementMedicine18%
  2. Cardiovascular Function and Risk FactorsMedicine14.9%
  3. Mechanical Circulatory Support DevicesEngineering9.1%
  4. Cardiac Structural Anomalies and RepairMedicine6.5%
  5. Cardiac pacing and defibrillation studiesMedicine5.4%
  6. Cardiac Fibrosis and RemodelingMedicine4.9%
  7. Cardiomyopathy and Myosin StudiesMedicine4.6%
  8. Transplantation: Methods and OutcomesMedicine4.4%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
LevelCategoryZone
MajorMedicineZone 1
MinorCardiac & Cardiovascular SystemsZone 2

Top journal: yesReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
LevelCategoryZone
MajorMedicineZone 1
MinorCardiac & Cardiovascular SystemsZone 2

Top journal: yesReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
LevelCategoryZone
MajorMedicineZone 1
MinorCardiac & Cardiovascular SystemsZone 2

Top journal: yesReview journal: no

Database indexing

SCIEScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor
8.24LetPub ·
CiteScore 2026-06
10.6LetPub ·
SJR 2026-06
2.41LetPub ·
SNIP 2026-06
1.97LetPub ·
h-index
88LetPub ·
h-index
172OpenAlex ·
i10-index
1,710OpenAlex ·
2-year mean citedness
4.84OpenAlex ·
Self-citation rate
2.4%LetPub ·
Share of gold OA articles
22.18%LetPub ·

Volume

Articles per year
98LetPub ·

Articles by year OpenAlex count · 2,895 in total · the current year is incomplete

YearArticlesOpen accessCitations
202616262126
202518689730
2024172911,659
2023131961,831
20221571383,651
20212081815,729

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with Crossref · to

160 daysMedian, submission to acceptance · P25–P75 108 days – 206 days

Acceptance to online
median 34 days (57 articles)
Submission to online
median 216 days
Sample
57 articles with submission and acceptance dates (404 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Average review time (community reports)
6–12 weeksLetPub ·
Average acceptance (community reports)
Fairly hardLetPub ·

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Hybrid open accessLetPub

A subscription journal in which authors can pay to publish their article open access.

No source has fee information yet; check the journal's website.

A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Profile

Publication details and official links

Publisher
Lippincott Williams and Wilkins Ltd.
Country or region
UNITED STATES
Language
English
Frequency
Bimonthly
Founded
2008
ISSN
1941-3289
Electronic ISSN
1941-3297
Official links

FAQ

Frequently asked questions about Circulation-Heart Failure

What CAS zone is Circulation-Heart Failure in?

In the 2025 upgraded edition of the CAS Journal Ranking, Circulation-Heart Failure is in Zone 1 of Medicine, and in Zone 2 of the minor category Cardiac & Cardiovascular Systems; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of Circulation-Heart Failure?

The latest impact factor listed by LetPub is 8.24; CiteScore 10.6, h-index 172.

How long does peer review take at Circulation-Heart Failure?

Based on the dates recorded on 57 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 160 days (interquartile range 108–206 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Fairly hard”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Which databases index Circulation-Heart Failure?

According to LetPub and DOAJ records, Circulation-Heart Failure is indexed in SCIE and Scopus.

Is Circulation-Heart Failure open access, and what is the APC?

Circulation-Heart Failure is a hybrid journal. Fee information is not available yet; check the journal's website.

Sources and updates

The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .